Drugs / JKN2304
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07450482 | Jul → Sep 2025 | chronic obstructive pulmonary disease | Joincare Pharmaceutical Group Industry Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JKN2304 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07450482 ↗ |
| Route | Other | “Administered via nebulizer.” NCT07450482 ↗ |